Tango Therapeutics, Inc. (TNGX) › Weighted Average Diluted SharesTango Therapeutics, Inc. (TNGX) — Weighted Average Diluted SharesAnnual figures by period end, from SEC filings.2021-12-31: 62.11M2022-12-31: 87.82M2023-12-31: 94.57M2024-12-31: 109.23M2025-12-31: 116.17M116.17M2021-12-31Weighted Average Diluted Shares (shares)2025-12-31Period endedWeighted Average Diluted SharesChange YoYSource filing2025-12-31116.17M+6.4%2026-03-05From 2025-01-012024-12-31109.23M+15.5%2026-03-05From 2024-01-012023-12-3194.57M+7.7%2026-03-05From 2023-01-012022-12-3187.82M+41.4%2025-02-27From 2022-01-012021-12-3162.11M—2023-03-27From 2021-01-01Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareEPS (Basic)